Search research articles
Contact Us
Filters
Showing results (31-40 of 155) with videos related to
Page
of 16
Sort By:
The Journal of Trauma and Acute Care Surgery
|
July 20, 2022
Sirtuin 1 deletion increases inflammation and mortality in sepsis
Hanna E Labiner, Kelli M Sas, Joseph A Baur, et al.
Surgical Infections
|
November 28, 2023
<i>Sirt3</i> Deletion Increases Inflammation and Mortality in Polymicrobial Sepsis
Hanna E Labiner, Kelli M Sas, Joseph A Baur, et al.
Geroscience
|
January 19, 2021
Longevity pathways in stress resistance: targeting NAD and sirtuins to treat the pathophysiology of hemorrhagic shock
Carrie A Sims, Hanna E Labiner, Sohini S Shah, et al.
Exercise and Sport Sciences Reviews
|
March 9, 2011
Mitochondrial protection by resveratrol
Zoltan Ungvari, William E Sonntag, Rafael de Cabo, et al.
Frontiers in Genetics
|
September 14, 2012
Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
Lan Ye, Behzad Varamini, Dudley W Lamming, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
June 16, 2023
Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop
Sara E Espinoza, Sundeep Khosla, Joseph A Baur, et al.
Nature
|
July 26, 2023
CAR T therapy beyond cancer: the evolution of a living drug
Daniel J Baker, Zoltan Arany, Joseph A Baur, et al.
Human Molecular Genetics
|
October 2, 2025
Sleep in a mouse model of fragile X syndrome is resistant to metabolic manipulations
Mariela Lopez Valencia, Ricardo A Velázquez Aponte, Joseph A Baur, et al.
Sleep
|
September 22, 2023
Sleep deprivation and aging are metabolically linked across tissues
Arjun Sengupta, Jennifer C Tudor, Danielle Cusmano, et al.
Nature Reviews. Drug Discovery
|
June 2, 2012
Are sirtuins viable targets for improving healthspan and lifespan?
Joseph A Baur, Zoltan Ungvari, Robin K Minor, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 155) with videos related to
Sort By:
Page
of 16
The Journal of Trauma and Acute Care Surgery
|
July 20, 2022
Sirtuin 1 deletion increases inflammation and mortality in sepsis
Hanna E Labiner, Kelli M Sas, Joseph A Baur, et al.
Surgical Infections
|
November 28, 2023
<i>Sirt3</i> Deletion Increases Inflammation and Mortality in Polymicrobial Sepsis
Hanna E Labiner, Kelli M Sas, Joseph A Baur, et al.
Geroscience
|
January 19, 2021
Longevity pathways in stress resistance: targeting NAD and sirtuins to treat the pathophysiology of hemorrhagic shock
Carrie A Sims, Hanna E Labiner, Sohini S Shah, et al.
Exercise and Sport Sciences Reviews
|
March 9, 2011
Mitochondrial protection by resveratrol
Zoltan Ungvari, William E Sonntag, Rafael de Cabo, et al.
Frontiers in Genetics
|
September 14, 2012
Rapamycin has a biphasic effect on insulin sensitivity in C2C12 myotubes due to sequential disruption of mTORC1 and mTORC2
Lan Ye, Behzad Varamini, Dudley W Lamming, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
June 16, 2023
Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop
Sara E Espinoza, Sundeep Khosla, Joseph A Baur, et al.
Nature
|
July 26, 2023
CAR T therapy beyond cancer: the evolution of a living drug
Daniel J Baker, Zoltan Arany, Joseph A Baur, et al.
Human Molecular Genetics
|
October 2, 2025
Sleep in a mouse model of fragile X syndrome is resistant to metabolic manipulations
Mariela Lopez Valencia, Ricardo A Velázquez Aponte, Joseph A Baur, et al.
Sleep
|
September 22, 2023
Sleep deprivation and aging are metabolically linked across tissues
Arjun Sengupta, Jennifer C Tudor, Danielle Cusmano, et al.
Nature Reviews. Drug Discovery
|
June 2, 2012
Are sirtuins viable targets for improving healthspan and lifespan?
Joseph A Baur, Zoltan Ungvari, Robin K Minor, et al.
Page
of 16